Eric Lefebvre
Technik-/Wissenschafts-/F&E-Leiter bei PLIANT THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Eric Lefebvre
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PLIANT THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2018 | - |
The CIHR Canadian HIV Trials Network
The CIHR Canadian HIV Trials Network Miscellaneous Commercial ServicesCommercial Services CIHR Canadian HIV Trials Network develops treatments, preventions, and a cure for HIV and related health conditions. The company was founded by Martin Schechter, John Ruedy and Julio Montaner in 1990 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
Canadian Association For HIV Research | Corporate Officer/Principal | - | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Eric Lefebvre
Ehemalige bekannte Positionen von Eric Lefebvre
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYMABAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.03.2022 | 22.03.2024 |
Independent Dir/Board Member | 21.03.2022 | 22.03.2024 | |
ALLERGAN PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2016 | 01.04.2018 |
TOBIRA THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.11.2016 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | 01.01.2007 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01.01.2001 | 01.01.2003 |
░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Eric Lefebvre
University of Montréal | Doctorate Degree |
College d'Enseignement General et Prof. Edouard-Montpetit | Undergraduate Degree |
Statistik
International
Kanada | 7 |
Vereinigte Staaten | 6 |
Belgien | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PLIANT THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
Tobira Therapeutics, Inc. /Old/
Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA. | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
The CIHR Canadian HIV Trials Network
The CIHR Canadian HIV Trials Network Miscellaneous Commercial ServicesCommercial Services CIHR Canadian HIV Trials Network develops treatments, preventions, and a cure for HIV and related health conditions. The company was founded by Martin Schechter, John Ruedy and Julio Montaner in 1990 and is headquartered in Vancouver, Canada. | Commercial Services |
Canadian Association For HIV Research | |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | Finance |
- Börse
- Insiders
- Eric Lefebvre
- Erfahrung